Ionis Pharmaceuticals (IONS) Leases (2021 - 2025)
Historic Leases for Ionis Pharmaceuticals (IONS) over the last 7 years, with Q3 2025 value amounting to $242.0 million.
- Ionis Pharmaceuticals' Leases rose 4717.62% to $242.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $242.0 million, marking a year-over-year increase of 4717.62%. This contributed to the annual value of $161.9 million for FY2024, which is 584.07% down from last year.
- According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Leases is $242.0 million, which was up 4717.62% from $163.9 million recorded in Q2 2025.
- Over the past 5 years, Ionis Pharmaceuticals' Leases peaked at $242.0 million during Q3 2025, and registered a low of $18.0 million during Q4 2021.
- For the 5-year period, Ionis Pharmaceuticals' Leases averaged around $163.8 million, with its median value being $169.4 million (2024).
- Its Leases has fluctuated over the past 5 years, first surged by 91003.67% in 2022, then tumbled by 599.77% in 2025.
- Quarter analysis of 5 years shows Ionis Pharmaceuticals' Leases stood at $18.0 million in 2021, then skyrocketed by 910.04% to $181.5 million in 2022, then fell by 5.31% to $171.9 million in 2023, then fell by 5.84% to $161.9 million in 2024, then skyrocketed by 49.51% to $242.0 million in 2025.
- Its Leases was $242.0 million in Q3 2025, compared to $163.9 million in Q2 2025 and $159.3 million in Q1 2025.